CONFERENCE HIGHLIGHTS
Robbins Learning Pavilion, RAH | November 7, 2026

WHAT IS THE CV UPDATE?
This one-day course will provide participants with practical and up to date information on the management of cardiac problems in the primary care setting. The conference will include a combination of workshops, presentations, and short snappers, as well as opportunities for the delegates and faculty to interact.
WHO SHOULD ATTEND?
Urban and rural primary care physicians as well as internists, ER doctors, nurse and nurse practitioners, fellows, residents, medical students, and allied health professionals.
WHAT ARE THE 2026 COURSE OBJECTIVES?
After attending this conference participants will be able to:
- Apply contemporary guideline-based approaches to assess and manage hypertension and other major modifiable cardiovascular risk factors.
- Recognize the cardiovascular implications of menopause and hormone therapy and incorporate these considerations into cardiovascular risk assessment and prevention in women.
- Interpret common ECG, ambulatory rhythm monitoring, and cardiac device findings and identify abnormalities requiring further investigation or specialist referral.
- Select appropriate cardiovascular investigations and management strategies for common outpatient presentations, including contemporary approaches to valvular heart disease.
- Optimize secondary prevention in patients with ASCVD using individualized lipid-lowering strategies, including appropriate use of non-statin and PCSK9-targeted therapies and interpretation of lipoprotein(a).
- Apply contemporary, individualized approaches to heart failure management using guideline-directed therapies and patient-specific factors.
- Describe advances in STEMI systems of care and identify strategies to improve timely, coordinated, and equitable management of acute myocardial infarction.
- Integrate evidence-based and emerging approaches to cardiovascular prevention and healthy longevity, including lifestyle modification, vaccination, and strategies to reduce lifetime cardiovascular risk.

